DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Household
Updated 1d ago
PG logo

The Procter & Gamble CompanyNYSE:PG Stock Report

Market Cap US$341.5b
Updated 1d ago
Share Price
n/a
1Y-6.2%
7D3.2%
1D0.4%
Portfolio Value
​
View

The Procter & Gamble Company

NYSE:PG Stock Report

Market Cap: US$341.5b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Procter & Gamble (PG) Stock Overview

Provides branded consumer packaged goods worldwide. More details

PG fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance3/6
Financial Health3/6
Dividends5/6

Rewards

Trading at 25.1% below our estimate of its fair value

Earnings are forecast to grow 3.89% per year

Earnings have grown 3% per year over the past 5 years

Pays a reliable dividend of 2.95%

Risk Analysis

Has a high level of debt

Significant insider selling over the past 3 months


PG Community Fair Values

Create Narrative

See what 667 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
9.7% undervalued intrinsic discount
AnalystConsensusTarget
•3mo ago

PG: Share Buyback And Product Rollout Will Drive Long-Term Upside

2.5k
0
324

Top Community Narratives

YI
20.6% overvalued intrinsic discount
yiannisz
•7mo ago

Procter & Gamble: Why Brain Health Is Emerging as the Next Consumer Wellness Frontier

209
0
32
AN
andre_santos
37.2% overvalued intrinsic discount
andre_santos
•1mo ago

Procter & Gamble - A Fundamental Valuation

3.5k
3
33
RO
Robbo
Emerging Author
1.6% undervalued intrinsic discount
Robbo
•9mo ago

Insiders Sell, Investors Watch: What’s Going On at PG?

468
0
14

Top Community Narratives

YI
20.6% overvalued intrinsic discount
yiannisz
•7mo ago

Procter & Gamble: Why Brain Health Is Emerging as the Next Consumer Wellness Frontier

209
0
32
AN
andre_santos
37.2% overvalued intrinsic discount
andre_santos
•1mo ago

Procter & Gamble - A Fundamental Valuation

3.5k
3
33
RO
Robbo
Emerging Author
1.6% undervalued intrinsic discount
Robbo
•9mo ago

Insiders Sell, Investors Watch: What’s Going On at PG?

468
0
14

Top Analyst Narratives

PG logo
Procter & Gamble
9.7% undervalued intrinsic discount

PG: Share Buyback And Product Rollout Will Drive Long-Term Upside

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 16 Jun
Read Narrative
View all narratives

The Procter & Gamble Company Competitors

Colgate-Palmolive

Symbol: NYSE:CL
Market cap: US$69.4b

Kimberly-Clark

Symbol: NasdaqGS:KMB
Market cap: US$32.6b

Church & Dwight

Symbol: NYSE:CHD
Market cap: US$22.7b

Clorox

Symbol: NYSE:CLX
Market cap: US$10.3b

Price History & Performance

Summary of share price highs, lows and changes for Procter & Gamble
Historical stock prices
Current Share PriceUS$147.55
52 Week HighUS$167.25
52 Week LowUS$137.62
Beta0.38
1 Month Change2.86%
3 Month Change-1.88%
1 Year Change-6.21%
3 Year Change-3.02%
5 Year Change2.33%
Change since IPO10,053.99%

Recent News & Updates

Seeking Alpha • Sep 04

Procter & Gamble: Minimal EPS Growth On The Horizon Limits The Upside

Summary The Procter & Gamble Company remains a well-run business, but its shares are unattractive at 21.15x FY27 EPS with only 1.3% expected growth. Procter & Gamble's 2.95% dividend yield is now less compelling than risk-free Treasuries, with slowing dividend growth and limited capital appreciation prospects. Fiscal 2027 guidance calls for 1–3% organic sales growth and 1.5% core EPS growth, with significant cost headwinds and Q1 EPS expected down 5%+. I remain neutral on Procter & Gamble, requiring a >4% yield and ~15x earnings (~$105–$110/share) before considering entry; index funds and Treasuries offer better alternatives. Read the full article on Seeking Alpha

Recent updates

Seeking Alpha • Sep 04

Procter & Gamble: Minimal EPS Growth On The Horizon Limits The Upside

Summary The Procter & Gamble Company remains a well-run business, but its shares are unattractive at 21.15x FY27 EPS with only 1.3% expected growth. Procter & Gamble's 2.95% dividend yield is now less compelling than risk-free Treasuries, with slowing dividend growth and limited capital appreciation prospects. Fiscal 2027 guidance calls for 1–3% organic sales growth and 1.5% core EPS growth, with significant cost headwinds and Q1 EPS expected down 5%+. I remain neutral on Procter & Gamble, requiring a >4% yield and ~15x earnings (~$105–$110/share) before considering entry; index funds and Treasuries offer better alternatives. Read the full article on Seeking Alpha
User avatar
Narrative Update • Aug 08

10-K Update

Updated with the most recent annual report.
Analysis Article • Aug 02

Analysts Have Made A Financial Statement On The Procter & Gamble Company's (NYSE:PG) Full-Year Report

Last week saw the newest yearly earnings release from The Procter & Gamble Company ( NYSE:PG ), an important milestone...
Analysis Article • Jun 21

Procter & Gamble (PG) Stock Could Be 19.5% Undervalued After Broad Based Growth

Procter & Gamble (PG) is back in the spotlight after reporting broad-based growth across core brands like Tide, Pampers, and Gillette, along with fresh marketing moves and continued dividend and buyback activity. See our latest analysis for Procter & Gamble. Despite the fresh product launches and media partnerships, Procter & Gamble’s recent share price return has been steady rather than dramatic, with a 30-day share price return of 4.11% and a 90-day share price return of 4.44%, while the...
User avatar
Narrative Update • Jun 16

PG: Cost Productivity And AI Investments Will Support Future Shareholder Returns

Analysts have slightly reduced their price target on Procter & Gamble to about $163.43 from about $163.77, reflecting small adjustments to revenue growth expectations, profit margin assumptions and the projected future P/E multiple. What's in the News P&G raised its quarterly dividend by 3% to US$1.0885 per share, marking the 70th consecutive annual increase, and plans to return about US$15b to shareholders in fiscal 2026 through roughly US$10b in dividends and US$5b in share repurchases.
User avatar
Narrative Update • Jun 01

PG: Cost Productivity And Portfolio Strength Will Support Future Shareholder Returns

Analysts have slightly reduced their price target on Procter & Gamble to $163.77 from $164.09, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News P&G reported fiscal Q3 2026 net sales of US$21.24b with 3% organic sales growth and core EPS of US$1.59, ahead of analyst expectations, while maintaining full year 2026 guidance for core EPS of US$6.83 to US$7.09 and organic sales growth of 1% to 5% (source: Q3 2026 earnings reports).
User avatar
Narrative Update • May 04

PG: Brand Partnerships And Product Pipeline Will Support Future Shareholder Returns

Analysts have trimmed their Procter & Gamble price target slightly to about $164.09, reflecting modestly lower assumptions for revenue and profit margins while applying a slightly higher future P/E outlook. What's in the News P&G maintained fiscal 2026 guidance, with all-in sales growth expected in a 1% to 5% range and diluted EPS growth targeted in a 1% to 6% range versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).
User avatar
Narrative Update • Apr 20

PG: Buybacks And Brand Partnerships Will Support Future Shareholder Returns

Analysts have slightly reduced their price target on Procter & Gamble to $164.18 from $166.95, reflecting modestly lower assumptions for revenue growth, profit margins, fair value, and future P/E multiples. What's in the News P&G revised its fiscal 2026 diluted EPS growth outlook to a range of 1% to 6%, from a prior range of 3% to 9%, citing higher non core restructuring charges, while keeping all in sales growth guidance at 1% to 5% versus the prior year (Corporate guidance).
User avatar
Narrative Update • Apr 05

PG: Share Repurchases And Premium Portfolio Refresh Will Support Future Returns

Analysts have slightly reduced their average price target for Procter & Gamble to about $167 from $168, reflecting updated views on margins and forward P/E assumptions while keeping core growth expectations largely intact. What's in the News OLAY shared new skin aging research at the 2026 American Academy of Dermatology meeting, focusing on cell adhesion as a key factor in visible aging and applying these findings to peptide based products across the Regenerist line and the new Regenerist Treatments collection (Product announcement).
User avatar
Narrative Update • Mar 22

PG: Product Refresh And Buybacks Will Support Future Earnings Resilience

Analysts kept their Procter & Gamble price target steady at $168. This reflects largely unchanged views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.
User avatar
Narrative Update • Mar 08

PG: Brand Refresh And Buybacks Will Support Stable Earnings Outlook

Analysts have maintained their Procter & Gamble price target at $168, reflecting unchanged assumptions around revenue growth, profit margins, and future P/E. This suggests that recent research has not materially shifted their valuation view.
User avatar
Narrative Update • Feb 21

PG: Brand Activity And Buybacks Will Support Stable Margins And Outlook

Analysts have nudged their price target for Procter & Gamble higher to $168.00 from $167.45, reflecting updated assumptions for revenue growth, slightly higher profit margins and a marginally lower future P/E multiple. What's in the News Tide launched Tide evo, a 100% concentrated, waterless laundry tile with six cleaning layers and no plastic bottles, positioned to address demand for products that align with hygiene and sustainability preferences in the U.S. (Product related announcement) Head & Shoulders introduced BARE Itchy Scalp Relief Serum, aimed at providing clinically tested dandruff protection and itch relief between washes, with a nationwide U.S. launch planned for January 2026.
User avatar
Narrative Update • Feb 07

PG: Premium Brand Extensions And Stable Margins Will Support A Balanced Outlook

Analysts have nudged their price target on Procter & Gamble slightly higher to US$167.45 from about US$165.32, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Old Spice launched the Spice Alchemist collection, a premium cologne-infused deodorant, body wash and body mist line positioned against high end fragrances.
User avatar
Narrative Update • Jan 25

Q2 2026 Update

Update narrative with most recent financial statements.
User avatar
Narrative Update • Jan 23

PG: Share Repurchases And Margin Pressures Will Shape A Balanced Outlook

Analysts have trimmed their price target on Procter & Gamble to US$165 from US$168, citing updated views on revenue growth, profit margins, and the future P/E multiple. What's in the News P&G updated its fiscal 2026 guidance, keeping all in sales growth for the year in a range of 1% to 5% versus the prior year, while lowering the diluted EPS growth outlook to 1% to 6% from the previous 3% to 9% range, citing higher non core restructuring charges versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).
User avatar
Narrative Update • Jan 07

PG: Share Repurchase Will Support Future Upside With Stable Long Term Outlook

Narrative Update on Procter & Gamble The analyst price target for Procter & Gamble has shifted slightly, with updated assumptions around fair value at about $168.13, discount rate at 6.96%, revenue growth at roughly 3.12%, profit margin near 19.58%, and future P/E around 26.08x, as analysts fine tune their models on the company. What's in the News Pantene is partnering again with social media creator Alix Earle to promote the Abundant & Strong 3-Step System, including limited-edition Alix x Pantene Kits that bundle the three products with a free cosmetics bag and hairbrush for a limited time (product-related announcement).
User avatar
Narrative Update • Dec 16

PG: Share Repurchase Will Support Future Upside Amid Stable Long Term Outlook

Analysts have nudged their price target for Procter & Gamble slightly lower to approximately $168.50 from about $169.05, reflecting modestly softer long term revenue growth expectations that are only partially offset by a marginally improved profit margin outlook and a slightly lower assumed future valuation multiple. What's in the News Pantene launched the Abundant & Strong Collection, a three step system clinically shown to reduce hair loss by up to 85% by targeting scalp oxidative stress with a Pro Vitamin Complex plus Niacinamide technology.
User avatar
Narrative Update • Dec 02

PG: Share Repurchase And New Collections Will Drive Continued Momentum

Procter & Gamble's analyst price target remains unchanged at $169.05 as analysts maintain stable estimates based on consistent fair value metrics and minimal adjustments to key financial assumptions. What's in the News Pantene launches the Abundant & Strong Collection, a new three-step system designed to reduce hair loss by up to 85% and promote stronger, denser hair using antioxidant technology.
User avatar
Narrative Update • Nov 18

PG: Share Buybacks And New Guidance Will Support Steady Uptrend

Analysts have maintained Procter & Gamble's price target at $169.05 per share. There have been only minor adjustments to underlying valuation factors, supporting a steady outlook for the company.
User avatar
Narrative Update • Nov 03

PG: Share Buyback And Product Rollout Will Drive Long-Term Upside

Analysts have slightly raised their price target for Procter & Gamble to $169.05 from $168.64. They cite incremental improvements in revenue growth forecasts even as profit margin projections moderate.
User avatar
Narrative Update • Oct 20

Rising Consumer Confidence And Product Investment Will Expand US Markets

Analysts have slightly lowered their price target for Procter & Gamble from $170.95 to $168.64 per share. They cite modest reductions in projected revenue growth, which are partially offset by improved profit margins and valuation multiples.

Shareholder Returns

PGUS Household ProductsUS Market
7D3.2%2.8%0.5%
1Y-6.2%-6.8%12.0%

Return vs Industry: PG matched the US Household Products industry which returned -6.8% over the past year.

Return vs Market: PG underperformed the US Market which returned 12% over the past year.

Price Volatility

Is PG's price volatile compared to industry and market?
PG volatility
PG Average Weekly Movement2.7%
Household Products Industry Average Movement3.8%
Market Average Movement6.8%
10% most volatile stocks in US Market15.2%
10% least volatile stocks in US Market2.9%

Stable Share Price: PG has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: PG's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1837104,000Shailesh Jejurikarwww.pginvestor.com

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands.

The Procter & Gamble Company Fundamentals Summary

How do Procter & Gamble's earnings and revenue compare to its market cap?
PG fundamental statistics
Market capUS$341.48b
Earnings (TTM)US$15.75b
Revenue (TTM)US$87.03b
21.8x
P/E Ratio
3.9x
P/S Ratio

Is PG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PG income statement (TTM)
RevenueUS$87.03b
Cost of RevenueUS$42.76b
Gross ProfitUS$44.28b
Other ExpensesUS$28.52b
EarningsUS$15.75b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Oct 22, 2026

Earnings per share (EPS)6.78
Gross Margin50.87%
Net Profit Margin18.10%
Debt/Equity Ratio62.9%

How did PG perform over the long term?

See historical performance and comparison

Dividends

3.0%
Current Dividend Yield
63%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/17 04:02
End of Day Share Price 2026/09/17 00:00
Earnings2026/06/30
Annual Earnings2026/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

The Procter & Gamble Company is covered by 40 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher GrajaArgus Research Company
Lauren LiebermanBarclays
Bethan DaviesBerenberg

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide